Eli Lilly and Company -
Links shared publicly online about this topic.
- 1,757total visits
Eli Lilly and Company -
View full resource at newsroom.lilly.com
Tags: Pain, Back Pain, Eli Lilly and Company
Most Recently Shared on September 11, 2009 at 2:28 pm By:
New Lilly Data Show Patients With Chronic Low Back Pain on Cymbalta(R) http://bit.ly/bPvoX
Why Eli Lilly's Alzheimer's Imaging Test Is No Breakthrough - Forbes
forbes.com — “Why the new Alzheimer's test is only a baby step toward early detection.” View full resource at forbes.com
Most Recently Shared on April 9, 2012 at 5:06 pm By:
Why Eli Lilly's Alzheimer's Imaging Test Is No Breakthrough: Sometimes (not always, certainly, but sometimes), M... http://t.co/VwznkQ5L
FDA Approves Alzheimer's Test Developed by Eli Lilly - WSJ.com
online.wsj.com — “The FDA approved an Eli Lilly test that can help detect Alzheimer's—a potential boon to treatment and developing drugs against the disease.” View full resource at online.wsj.com
Most Recently Shared on April 8, 2012 at 11:34 pm By:
Alzheimer Diagnosis Possible With Scan - Wall Street Journal http://t.co/gle8vhJV #health
U.S. gives nod to Eli Lilly's brain plaque test | Reuters
reuters.com — “WASHINGTON (Reuters) - U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer's disease, the company said.The” View full resource at reuters.com
Most Recently Shared on April 8, 2012 at 3:30 am By:
U.S. gives nod to Eli Lilly's brain plaque test http://t.co/1dVbx3gl via @zite
Lilly says FDA approves brain imaging agent - Yahoo! News
news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said late Friday that the Food and Drug Administration approved Amyvid, a diagnostic imaging agent that is intended to help diagnose Alzheimer's disease.” View full resource at news.yahoo.com
Most Recently Shared on April 7, 2012 at 11:39 pm By:
Lilly says FDA approves brain imaging agent: Eli Lilly and Co. said late Friday that the Food and Drug Administr... http://t.co/KiJpJNHt
NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH
highlighthealth.com — “The National Institutes of Health and Eli Lilly and Company announced that they will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines.” View full resource at highlighthealth.com
Most Recently Shared on April 2, 2012 at 6:45 pm By:
NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive http://t.co/9JS7R7oK
Eli Lilly says psoriasis drug meets goal in study - Yahoo! News
news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said Wednesday its experimental psoriasis drug met its goals in a mid-stage clinical trial.” View full resource at news.yahoo.com
Most Recently Shared on March 29, 2012 at 2:20 am By:
Eli Lilly says psoriasis drug meets goal in study: Eli Lilly and Co. said Wednesday its experimental psoriasis d... http://t.co/QtU8mxce
Byetta cleared for add-on therapy with basal insulin in EU | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN) and drug major Eli Lilly (NYSE: LLY) said on Friday that the European Commission has granted marketing aut...” View full resource at bioportfolio.com
Most Recently Shared on March 26, 2012 at 9:37 am By:
BioPortfolio News Byetta cleared for addon therapy with basal insulin in EU: US biotech firm A... http://t.co/JKCjSA5t BioPortfolio News
Eli Lilly and Company - BYETTA® Approved for Use with Basal Insulin in Europe
newsroom.lilly.com — “Eli Lilly and Company - BYETTA® Approved for Use with Basal Insulin in Europe” View full resource at newsroom.lilly.com
Most Recently Shared on March 23, 2012 at 6:43 pm By:
BYETTA® Approved for Use with Basal Insulin in Europe (Lilly) http://t.co/W8GNvepK
European Commission grants marketing authorization for use of BYETTA with basal insulin
news-medical.net — “Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 1:57 pm By:
European Commission grants marketing authorization for use of BYETTA with basal insulin: Amylin Pharmaceuticals,... http://t.co/3EqmxLdM
Pfizer, Lilly and Sanofi help authorities break up counterfeiters - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “A gang believed to be importing fake drugs from Asia, including erectile dysfunction drug knockoffs, has been intercepted by authorities with the help of Pfizer ($PFE), Eli Lilly ($LLY) and Sanofi ( Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on March 21, 2012 at 4:20 pm By:
.@Pfizer @LillyPad and @SanofiUS help authorities break up drug counterfeiters http://t.co/FuCbxp6s
Lilly to focus on diabetes, cancer in China - FiercePharma
fiercepharma.com — “Eli Lilly ($LLY) has a plan to maintain sales growth, and it involves China, a big prize drugmakers having been eyeing over the last several years. CEO John Lechleiter (photo) wants Lilly to be the Read more...” View full resource at fiercepharma.com
Most Recently Shared on March 20, 2012 at 4:31 pm By:
Lilly to focus on diabetes, cancer in China - FiercePharma: http://t.co/R5xx10IG via @AddThis
Champion of My Heart » Blog Archive » Dog Blog Poll: Should a Vaccine Company Help Cover Costs When Vaccines Cause Expensive Outcomes?
championofmyheart.com — “Please take our dog blog poll about adverse vaccine reactions in dogs. Lilly, a border collie and the canine heroine of award-winning dog blog Champion of My Heart, developed meningoencephalomyelitis / meningoencephalitis (inflammation of the brain and lining of the brain and spinal cord) after an adverse reaction to a rabies vaccine given January 23, 2012.” View full resource at championofmyheart.com
Most Recently Shared on March 20, 2012 at 11:47 am By:
Dog Blog Poll: Should a Vaccine Company Help Cover Costs When Vaccines Cause Expensive Outco... http://t.co/DwnFpr6q via @champofmyheart
Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism
eurekalert.org — “European Autism Interventions ? A Multicentre Study for Developing New Medications led by Roche, King's College London, and Autism Speaks, is a collaboration with top scientists worldwide and drug companies from EFPIA including Roche, Eli Lilly, Servier, Janssen Pharmaceutica, Pfizer and Vifor Pharma to develop and validate translational research approaches for novel therapies; develop expert sites across Europe to run clinical trials; and create an interactive platform for ASD professionals and” View full resource at eurekalert.org
Most Recently Shared on March 19, 2012 at 1:24 pm By:
Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism: ( Autism Speaks )... http://t.co/4TW6Jdtc
Ex-Google exec says social media obsession is unraveling the company | Death and Taxes
deathandtaxesmag.com — “Ex-Google exec says social media obsession is unraveling the company | Death and Taxes” View full resource at deathandtaxesmag.com
Most Recently Shared on March 15, 2012 at 3:52 pm By:
Ex-Google exec says social media obsession is unraveling the company http://t.co/6EliH507
NIH and Lilly to generate public resource of approved and investigational medicines, March 13, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “The National Institutes of Health and Eli Lilly and Company will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of sophisticated disease-relevant testing systems, NIH announced today.” View full resource at nih.gov
Most Recently Shared on March 13, 2012 at 5:13 pm By:
#NCATS’ #pharmaceutical collection of 3,800 approved & investigational meds 2 B screened w/ #Lilly’s PD2 assay panel http://t.co/7sf29RY3
Advertisement

